However, tumor Tregs play a crucial role in suppressing tumor-specific CD8+ T cell responses in tumor-draining lymph nodes, thus impeding antitumor immunity at the initial stages of the immune response triggered by adoptively transferred tumor-primed CD4+ T cells (42). Here, CD8A is linked to neoplasm.